MabVax Therapeutics Holdings Inc. (fka MBVXQ)

[Amatuer17]

If you look at ASCO - there were many drugs from BP were mAB
So in my view MBVX is sitting on huge IP and range of mAB that are best in class.
However they all are in pre-clinical which means - years away from any meaningful progress in P1 or P2

Also with lack of funds - they cannot do simultaneous progress.

The best thing that can happen is good partnership or just plain BO - with current market cap 18.6 million - any BP CAN throw 100-200 million for IP - that can turn this into 5-10 bagger.